James C. Davis

Associate

davis-james-c-300
  • JD, Harvard Law School, 2012
  • AB, cum laude, Harvard College, 2006
  • Vordiplom, Humboldt-Universität zu Berlin, 2008

Qualifications

  • Illinois, 2012
  • German
  • Spanish

James C. Davis

Associate

Jim’s practice focuses on private equity buyouts and strategic M&A, including cross-border transactions, public and private mergers, asset management transactions, acquisitions and divestitures, and corporate governance. He also regularly represents providers of fairness and solvency opinions in connection with dividends, sale-leasebacks and other significant transactions.

Jim is active in pro bono representations and was honored by LAF Chicago as a 2016 Volunteer of the Year.

Experience

  • Represented Crane 1 Services, a portfolio company of Pfingsten Partners, in its acquisition of Crane Service & Inspections.
  • Represented Novanta in its acquisition of Trimble’s ThingMagic division, a provider of RFID technology.
  • Represented Equity International in the establishment of a joint venture between its portfolio company GuardeAqui and Kipit Self Storage, each a self-storage operator in Brazil.
  • Represented Mitsubishi Bank in its acquisition of Guggenheim Investments’ mutual fund administration business.
  • Represented Mitsubishi Bank in its acquisition of UBS Global Asset Management's Administrative Fund Services Business.
  • Represented Altamont Capital Partners in its acquisition of a majority stake in Celestite Holdings, a prominent non-standard auto insurance managing general agency.
  • Represented Cressey & Company in its sale of Encompass Home Healthcare to HealthSouth Corporation.
  • Represented BV Investment Partners in its sale of Butterfield Fulcrum Group and FORS Limited, each a hedge fund administrator, to Mitsubishi Bank.
  • Represented Pfingsten Partners in its acquisition of Allied Reliability Group, an international provider of predictive maintenance and condition-based monitoring services.
  • Represented TPG Capital and Immucor, Inc. in connection with Immucor’s acquisition of Organ-I, a provider of biotech diagnostics.
  • Represented a strategic buyer in its acquisition from a private equity fund of a leading provider of specialist physicians to hospitals.
  • Represents leading financial advisors in connection with providing solvency and fairness opinions.

Publications